Articles2 January 2001
    Author, Article, and Disclosure Information
    Background:

    Weight loss appears to be an effective method for primary prevention of hypertension. However, the long-term effects of weight loss on blood pressure have not been extensively studied.

    Objective:

    To present detailed results from the weight loss arm of Trials of Hypertension Prevention (TOHP) II.

    Design:

    Multicenter, randomized clinical trial testing the efficacy of lifestyle interventions for reducing blood pressure over 3 to 4 years. Participants in TOHP II were randomly assigned to one of four groups. This report focuses only on participants assigned to the weight loss (n = 595) and usual care control (n = 596) groups.

    Patients:

    Men and women 30 to 54 years of age who had nonmedicated diastolic blood pressure of 83 to 89 mm Hg and systolic blood pressure less than 140 mm Hg and were 110% to 165% of their ideal body weight at baseline.

    Intervention:

    The weight loss intervention included a 3-year program of group meetings and individual counseling focused on dietary change, physical activity, and social support.

    Measurements:

    Weight and blood pressure data were collected every 6 months by staff who were blinded to treatment assignment.

    Results:

    Mean weight change from baseline in the intervention group was −4.4 kg at 6 months, −2.0 kg at 18 months, and −0.2 kg at 36 months. Mean weight change in the control group at the same time points was 0.1, 0.7, and 1.8 kg. Blood pressure was significantly lower in the intervention group than in the control group at 6, 18, and 36 months. The risk ratio for hypertension in the intervention group was 0.58 (95% CI, 0.36 to 0.94) at 6 months, 0.78 (CI, 0.62 to 1.00) at 18 months, and 0.81 (CI, 0.70 to 0.95) at 36 months. In subgroup analyses, intervention participants who lost at least 4.5 kg at 6 months and maintained this weight reduction for the next 30 months had the greatest reduction in blood pressure and a relative risk for hypertension of 0.35 (CI, 0.20 to 0.59).

    Conclusions:

    Clinically significant long-term reductions in blood pressure and reduced risk for hypertension can be achieved with even modest weight loss.

    References

    • 1. Burt VLWhelton PRoccella EJBrown CCutler JAHiggins Met al Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension1995;25:305-13. CrossrefMedlineGoogle Scholar
    • 2. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med1997;157:2413-46. CrossrefMedlineGoogle Scholar
    • 3. Stamler JStamler RNeaton JDBlood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med1993;153:598-615. CrossrefMedlineGoogle Scholar
    • 4. Collins RPeto RMacMahon SHebert PFiebach NHEberlen KAet al Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiologic context. Lancet1990;335:827-38. CrossrefMedlineGoogle Scholar
    • 5. Hebert PRMoser MMayer JGlynn RJHennekens CHRecent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med1993;153:578-81. CrossrefMedlineGoogle Scholar
    • 6. Reisin EFrohlich EDMesserli FHDreslinski GRDunn FGJones MMet al Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med1983;98:315-9. LinkGoogle Scholar
    • 7. Langford HGBlaufox MDOberman AHawkins CMCurb JDCutter GRet al Dietary therapy slows the return of hypertension after stopping prolonged medication. JAMA1985;253:657-64. CrossrefMedlineGoogle Scholar
    • 8. Stamler RStamler JGrimm RGosch FCElmer PDyer Aet al Nutritional therapy for high blood pressure. Final report of a four-year randomized, controlled trial—the Hypertension Control Program. JAMA1987;257:1484-91. CrossrefMedlineGoogle Scholar
    • 9. Corrigan SARaczynski JMSwencionis CJennings SGWeight reduction in the prevention and treatment of hypertension: a review of representative clinical trials. Am J Health Promot1991;5:208-14. CrossrefMedlineGoogle Scholar
    • 10. Stamler RStamler JGosch FCCivinelli JFishman JMcKeever Pet al Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial. JAMA1989;262:1801-7. CrossrefMedlineGoogle Scholar
    • 11. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Hypertension Prevention Trial Research Group. Arch Intern Med1990;150:153-62. CrossrefMedlineGoogle Scholar
    • 12. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213-20. CrossrefMedlineGoogle Scholar
    • 13. MacMahon SCutler JBrittain EHiggins MObesity and hypertension: epidemiological and clinical issues. Eur Heart J1987;8 Suppl B 57-70. CrossrefMedlineGoogle Scholar
    • 14. Cutler JARandomized clinical trials of weight reduction in nonhypertensive persons. Ann Epidemiol1991;1:363-70. CrossrefMedlineGoogle Scholar
    • 15. Stevens VJCorrigan SAObarzanek EBernauer ECook NRHebert Pet al Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. Arch Intern Med1993;153:849-58. CrossrefMedlineGoogle Scholar
    • 16. Hebert PRBolt RJBorhani NOCook NRCohen JDCutler JAet al Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol1995;5:130-9. CrossrefMedlineGoogle Scholar
    • 17. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med1997;157:657-67. MedlineGoogle Scholar
    • 18. Metropolitan Life Insurance Co. 1983 Metropolitan height and weight tables. Statistical Bulletin1983;64:4. Google Scholar
    • 19. Hollis JFSatterfield SSmith FFouad MAllender PSBorhani Net al Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol1995;5:140-8. CrossrefMedlineGoogle Scholar
    • 20. Appel LJHebert PRCohen JDObarzanek EYamamoto MBuring Jet al Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol1995;5:149-55. CrossrefMedlineGoogle Scholar
    • 21. Wright BMDore CFA random-zero sphygmomanometer. Lancet1970;1:337-8. MedlineGoogle Scholar
    • 22. Lasser VIRaczynski JMStevens VJMattfeldt-Beman MKKumanyika SEvans Met al Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epide-miol1995;5:156-64. CrossrefMedlineGoogle Scholar
    • 23. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report. National Institutes of Health. Obes Res1998;6 Suppl 2 51S-209S. MedlineGoogle Scholar
    • 24. Meltzer AAEverhart JECorrelations with self-reported weight loss in overweight U.S. adults. Obes Res1996;4:479-86. CrossrefMedlineGoogle Scholar
    • 25. Kumanyaka SKObarzanek EStevens VJHebert PRWhelton PKWeight-loss experience of black and white participants in NHLBI-sponsored clinical trials. Am J Clin Nutr1991;53:1631S-1638S. CrossrefMedlineGoogle Scholar
    • 26. Wadden TAFoster GDWang JPierson RNYang MUMoreland Ket al Clinical correlates of short- and long-term weight loss. Am J Clin Nutr1992;56:271S-274S. CrossrefMedlineGoogle Scholar
    • 27. Fitzwater SLWeinsier RLWooldridge NHBirch RLiu CBartolucci AAEvaluation of long-term weight changes after a multidisciplinary weight control program. J Am Diet Assoc1991;91:421-6, 429. CrossrefMedlineGoogle Scholar
    • 28. Perri MGSears SFClark JEStrategies for improving maintenance of weight loss. Toward a continuous care model of obesity management. Diabetes Care1993;16:200-9. CrossrefMedlineGoogle Scholar
    • 29. Perri MGNezu AMPatti ETMcCann KPEffect of length of treatment on weight loss. Journal of Consulting and Clinical Psychology1989;57:450-2. CrossrefMedlineGoogle Scholar
    • 30. Sodium, potassium, body mass, alcohol and blood pressure: the INTERSALT Study. The INTERSALT Co-operative Research Group. J Hypertens Suppl1988;6:S584-6. CrossrefMedlineGoogle Scholar
    • 31. Wing RRJeffery RWHellerstedt WLA prospective study of effects of weight cycling on cardiovascular risk factors. Arch Intern Med1995;155:1416-22. CrossrefMedlineGoogle Scholar